The global Alu-PVC blister packaging market is valued at USD 5,579.9 million in 2025 and is set to reach USD 9,002.9 million by 2035, growing at a CAGR of 4.9%. The market stands at the forefront of a transformative decade that promises to redefine pharmaceutical packaging technologies and protective barrier systems across pharmaceutical manufacturing, healthcare distribution, and medical device applications. The market's journey from USD 5,579.9 million in 2025 to USD 9,002.9 million by 2035 represents substantial growth, demonstrating the accelerating adoption of aluminum-PVC barrier technologies and advanced blister packaging solutions across pharmaceutical operations, healthcare logistics, and critical product protection applications.
Pharmaceutical sector modernization continues to accelerate adoption of Alu-PVC blister packaging, with industries ranging from pharmaceutical manufacturing to healthcare distribution implementing these packages as critical components in product protection systems. The growing focus on barrier properties, moisture protection, and product integrity creates continued demand for packaging solutions that deliver consistent performance while reducing contamination risks and improving patient compliance. Alu-PVC blister packages address these needs through advanced barrier technologies, enhanced protection capabilities, and robust construction that withstand demanding pharmaceutical and healthcare applications while providing superior product preservation and tamper resistance.
Regional market dynamics reveal distinct growth patterns influenced by pharmaceutical development levels, healthcare infrastructure capabilities, and blister packaging adoption rates. Developed markets in North America and Europe demonstrate steady growth driven by pharmaceutical modernization, regulatory compliance cycles, and advanced packaging processes that prioritize high-barrier protection systems. Emerging markets in Asia-Pacific show accelerated expansion supported by rapid healthcare development, pharmaceutical manufacturing growth, and increasing adoption of protective packaging technologies. The competitive landscape encompasses established packaging manufacturers alongside specialized barrier solution providers, creating a diverse ecosystem that serves various market segments with tailored solutions.
The first half of the decade (2025-2030) will witness the market climbing from USD 5,579.9 million to approximately USD 7,435.0 million, adding USD 1,855.1 million in value, which constitutes 54.2% of the total forecast growth period. This phase will be characterized by the rapid adoption of advanced Alu-PVC packaging technologies, driven by increasing demand for pharmaceutical protection solutions and enhanced barrier capabilities worldwide. Superior moisture resistance and product integrity will become standard expectations rather than premium options.
The latter half (2030-2035) will witness continued growth from USD 7,435.0 million to USD 9,002.9 million, representing an addition of USD 1,567.9 million or 45.8% of the decade's expansion. This period will be defined by mass market penetration of specialized packaging systems, integration with comprehensive pharmaceutical platforms, and seamless compatibility with existing healthcare distribution infrastructure. The market trajectory signals fundamental shifts in how pharmaceutical facilities approach packaging selection, with participants positioned to benefit from continued demand across multiple application segments.
The market demonstrates distinct growth phases with varying market characteristics and competitive dynamics. Between 2025 and 2030, the market progresses through its pharmaceutical optimization phase, expanding from USD 5,579.9 million to USD 7,435.0 million with steady annual increments averaging 4.9% growth. This period showcases the transition from traditional packaging technologies to advanced Alu-PVC systems with enhanced barrier performance and integrated protection management becoming mainstream features.
The 2025-2030 phase adds USD 1,855.1 million to market value, representing 54.2% of total decade expansion. Market maturation factors include standardization of packaging specifications, declining production costs for Alu-PVC packages, and increasing pharmaceutical awareness of barrier protection reaching 85-90% effectiveness in healthcare applications. Competitive landscape evolution during this period features established manufacturers like AptarGroup and Tekni-Plex expanding their blister packaging portfolios while new entrants focus on specialized barrier solutions and enhanced pharmaceutical technology.
From 2030 to 2035, market dynamics shift toward comprehensive pharmaceutical integration and multi-application deployment, with growth continuing from USD 7,435.0 million to USD 9,002.9 million, adding USD 1,567.9 million or 45.8% of total expansion. This phase transition centers on universal Alu-PVC packaging systems, integration with advanced pharmaceutical platforms, and deployment across diverse healthcare scenarios, becoming standard rather than specialized packaging formats. The competitive environment matures with focus shifting from basic packaging performance to comprehensive barrier excellence and compatibility with modern pharmaceutical operations.
| Metric | Value |
|---|---|
| Market Value (2025) | USD 5,579.9 million |
| Market Forecast (2035) | USD 9,002.9 million |
| Growth Rate | 4.9% CAGR |
| Leading Type | Standard Blister Packs |
| Primary Application | Pharmaceutical Products Segment |
The market demonstrates strong fundamentals with Standard Blister Packs capturing a dominant share through superior barrier characteristics and pharmaceutical compatibility. Pharmaceutical product applications drive primary demand, supported by increasing protection requirements and enhanced healthcare development solutions. Geographic expansion remains concentrated in developed pharmaceutical markets with established infrastructure, while emerging economies show accelerating adoption rates driven by healthcare expansion and rising packaging sophistication.
The Alu-PVC blister packaging market represents a compelling intersection of pharmaceutical innovation, barrier protection advancement, and healthcare optimization management. With robust growth projected from USD 5,579.9 million in 2025 to USD 9,002.9 million by 2035 at a 4.9% CAGR, this market is driven by increasing pharmaceutical protection expansion trends, advanced barrier requirements, and demand for high-performance packaging formats.
The market's expansion reflects a fundamental shift in how pharmaceutical facilities and healthcare operators approach packaging infrastructure. Strong growth opportunities exist across diverse applications, from pharmaceutical operations requiring high-barrier packages to healthcare systems demanding reliable protection components. Geographic expansion is particularly pronounced in Asia-Pacific markets, led by China (6.6% CAGR) and India (6.1% CAGR), while established markets in North America and Europe drive innovation and specialized segment development.
The dominance of Standard Blister Packs and pharmaceutical product applications underscores the importance of proven packaging technology and pharmaceutical reliability in driving adoption. Packaging standardization and barrier complexity remain key challenges, creating opportunities for companies that can deliver seamless packaging performance while maintaining product integrity.
Market expansion rests on three fundamental shifts driving adoption across pharmaceutical and healthcare sectors. Pharmaceutical protection growth creates compelling advantages through Alu-PVC packaging systems that provide comprehensive barrier properties with operational compatibility, enabling manufacturers to manage increasing protection requirements and maintain quality standards while ensuring moisture-resistant operations and justifying investment over traditional packaging methods. Advanced barrier modernization accelerates as companies worldwide seek reliable packages that deliver superior protection directly to pharmaceutical systems, enabling contamination reduction that aligns with operational expectations and maximizes pharmaceutical productivity. Healthcare transformation drives adoption from distribution operators requiring specialized packages that maximize protection while maintaining high-quality reliability during pharmaceutical and healthcare operations.
Growth faces headwinds from advanced materials cost variations that differ across packaging suppliers regarding pricing stability and supply chain reliability, potentially limiting margin consistency in price-sensitive pharmaceutical categories. Manufacturing complexity also persists regarding packaging specifications and pharmaceutical requirements that may increase production costs in facilities with demanding quality standards.
Primary Classification: The market segments by type into Standard Blister Packs, Thermoformed Blister Packs, Cold-Formed Blister Packs, and others categories, representing the evolution from basic packaging solutions to high-barrier blister systems for comprehensive operations.
Secondary Breakdown: Application segmentation divides the market into pharmaceutical products, cosmetics products, and others sectors, reflecting distinct requirements for barrier characteristics, protection specifications, and operational performance.
Tertiary Classification: End-use industry segmentation covers pharmaceutical manufacturing, healthcare distribution, medical devices, consumer healthcare, hospital pharmacy, and retail pharmacy, representing diverse requirements for packaging specifications and application performance.
Regional Classification: Geographic distribution covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with developed pharmaceutical markets leading innovation while emerging economies show accelerating growth patterns driven by healthcare programs.
The segmentation structure reveals technology progression from standard packaging systems toward integrated high-performance platforms with enhanced barrier capabilities and precision performance, while application diversity spans from pharmaceutical systems to healthcare requiring comprehensive packaging properties and intelligent protection solutions.
Standard Blister Packs segment is estimated to account for 62.4% of the Alu-PVC blister packaging market share in 2025. The segment's leading position stems from its fundamental role as a critical component in modern pharmaceutical applications and its extensive use across multiple healthcare and pharmaceutical sectors. The Standard Blister Packs range's dominance is attributed to its superior barrier properties, including excellent moisture resistance, product protection, and balanced cost-effectiveness that make it indispensable for pharmaceutical operations.
Market Position: Standard Blister Packs command the leading position in the Alu-PVC blister packaging market through advanced packaging technologies, including comprehensive barrier properties, uniform protection, and reliable characteristics that enable operators to deploy packages across diverse pharmaceutical environments.
Value Drivers: The segment benefits from pharmaceutical preference for proven packaging interfaces that provide exceptional barrier performance without requiring ultra-premium packaging costs. Efficient protection implementation enables deployment in pharmaceutical, healthcare, and medical applications where packaging reliability and barrier compatibility represent critical selection requirements.
Competitive Advantages: Standard Blister Packs differentiate through excellent protection capacity, proven pharmaceutical reliability, and compatibility with standard pharmaceutical processes that enhance packaging capabilities while maintaining economical barrier profiles suitable for diverse healthcare applications.
Key market characteristics:
Pharmaceutical Products segment is projected to hold 74.3% of the Alu-PVC blister packaging market share in 2025. The segment's market leadership is driven by the extensive use of Alu-PVC packages in drug manufacturing, pharmaceutical systems, healthcare manufacturing, and medication infrastructure, where packages serve as both a protection component and barrier solution. The pharmaceutical sector's consistent demand for reliable packaging systems supports the segment's dominant position.
Market Context: Pharmaceutical applications dominate the market due to widespread adoption of efficient packaging solutions and increasing focus on pharmaceutical protection, performance optimization, and operational management that support pharmaceutical operations while maintaining quality standards.
Appeal Factors: Pharmaceutical consumers prioritize packaging durability, barrier performance, and integration with standard pharmaceutical systems that enable coordinated deployment across multiple pharmaceutical needs. The segment benefits from substantial drug manufacturing growth and pharmaceutical development that emphasize reliable packages for medication applications.
Growth Drivers: Pharmaceutical programs incorporate Alu-PVC packages as standard components for drug systems and healthcare programs. Healthcare compliance initiatives are increasing demand for advanced features that comply with pharmaceutical standards and enhance system performance.
Market Challenges: Packaging cost fluctuations and standardization requirements may limit deployment flexibility in ultra-price-sensitive markets or regions with varying pharmaceutical requirements.
Application dynamics include:
Pharmaceutical Manufacturing segment is anticipated to capture 58.1% of the Alu-PVC blister packaging market share in 2025. The segment's growth is driven by increasing drug production demand, pharmaceutical manufacturing initiatives, and sophisticated packaging requirements that require high-quality barrier systems. The pharmaceutical industry's expansion and focus on protection efficiency support this segment's robust performance.
Market Position: Pharmaceutical applications leverage Alu-PVC packages for drug systems in pharmaceutical equipment, manufacturing operations, production processes, and component integration where packaging quality and barrier precision are critical performance factors.
Growth Catalysts: Rising drug production volumes, pharmaceutical development trends, and expanding protection capabilities drive demand for specialized packages that deliver consistent performance across diverse pharmaceutical applications.
Growth Accelerators: Pharmaceutical protection expansion drives primary adoption as Alu-PVC packaging systems provide exceptional barrier properties that enable pharmaceutical development without contamination compromise, supporting protection advancement and operational efficiency that require reliable packaging formats. Advanced barrier growth accelerates market expansion as companies seek specialized packages that maintain integrity during operation while enhancing pharmaceutical convenience through standardized specifications and compatibility. Healthcare awareness increases worldwide, creating continued demand for Alu-PVC packaging systems that complement pharmaceutical routines and provide operational advantages in barrier performance.
Growth Inhibitors: Advanced material cost volatility challenges differ across packaging markets regarding price stability and supply chain consistency, which may limit margin predictability and cost planning in price-sensitive pharmaceutical categories with demanding affordability requirements. Manufacturing complexity persists regarding packaging specifications and pharmaceutical standards that may increase production costs in facilities with complex quality protocols. Market fragmentation across multiple packaging specifications and application standards creates compatibility concerns between different packaging systems and existing pharmaceutical infrastructure.
Market Evolution Patterns: Adoption accelerates in pharmaceutical and healthcare sectors where packaging benefits justify equipment investments, with geographic concentration in developed markets transitioning toward mainstream adoption in emerging economies driven by healthcare expansion. Technology advancement focuses on enhanced barrier properties, improved pharmaceutical performance, and integration with automated systems that optimize pharmaceutical performance and quality control. The market could face disruption if alternative packaging technologies or pharmaceutical changes significantly challenge traditional Alu-PVC packaging advantages in pharmaceutical applications.
The market demonstrates varied regional dynamics with growth leaders including China (6.6% CAGR) and India (6.1% CAGR) driving expansion through pharmaceutical infrastructure growth and healthcare modernization. Steady Performers encompass Germany (5.6% CAGR), Brazil (5.1% CAGR), and the USA (4.7% CAGR), benefiting from established pharmaceutical systems and advanced packaging adoption.
| Country | CAGR (2025-2035) |
|---|---|
| China | 6.6% |
| India | 6.1% |
| Germany | 5.6% |
| Brazil | 5.1% |
| USA | 4.7% |
| UK | 4.2% |
| Japan | 3.7% |
Regional synthesis reveals Asia-Pacific markets leading growth through pharmaceutical expansion and healthcare development, while European countries maintain steady expansion supported by specialized applications and precision packaging requirements. North American markets show strong growth driven by pharmaceutical demand and healthcare facility upgrades.
China establishes regional leadership through rapid pharmaceutical development and comprehensive healthcare modernization, integrating advanced Alu-PVC packaging systems as standard components in drug manufacturing and medical operations. The country's 6.6% CAGR through 2035 reflects pharmaceutical growth promoting infrastructure protection and healthcare development that mandate the use of reliable packaging systems in pharmaceutical operations. Growth concentrates in major pharmaceutical centers, including Beijing, Shanghai, and Guangzhou, where pharmaceutical networks showcase integrated packaging systems that appeal to manufacturers seeking enhanced production efficiency and international quality standards.
Chinese manufacturers are developing innovative Alu-PVC packaging solutions that combine local production advantages with international pharmaceutical specifications, including advanced barrier compositions and enhanced protection capabilities.
Strategic Market Indicators:
The Indian market emphasizes pharmaceutical infrastructure applications, including rapid healthcare development and comprehensive medical expansion that increasingly incorporates Alu-PVC packages for pharmaceutical enhancement and healthcare applications. The country is projected to show a 6.1% CAGR through 2035, driven by massive pharmaceutical activity under healthcare initiatives and demand for standardized, high-quality packaging systems. Indian pharmaceutical facilities prioritize cost-effectiveness with Alu-PVC packages delivering healthcare efficiency through economical packaging usage and reliable performance capabilities.
Technology deployment channels include major pharmaceutical companies, healthcare integrators, and medical institutions that support high-volume usage for pharmaceutical and healthcare applications.
Performance Metrics:
The German market emphasizes advanced pharmaceutical infrastructure features, including innovative packaging technologies and integration with comprehensive healthcare platforms that manage drug operations, pharmaceutical facilities, and institutional applications through unified packaging systems. The country is projected to show a 5.6% CAGR through 2035, driven by pharmaceutical expansion under healthcare development trends and demand for premium, reliable packaging systems. German pharmaceutical institutions prioritize precision with Alu-PVC packages delivering comprehensive healthcare performance through enhanced quality protection and operational innovation.
Technology deployment channels include major pharmaceutical companies, healthcare institutions, and packaging equipment manufacturers that support custom development for premium operations.
Performance Metrics:
In São Paulo, Rio de Janeiro, and Belo Horizonte, Brazilian pharmaceutical facilities and healthcare operators are implementing advanced Alu-PVC packaging systems to enhance barrier capabilities and support operational performance that aligns with pharmaceutical protocols and healthcare standards. The Brazilian market demonstrates continued growth with a 5.1% CAGR through 2035, driven by pharmaceutical compliance programs and healthcare investments that emphasize reliable packaging systems for pharmaceutical and medical applications. Brazilian pharmaceutical facilities are prioritizing Alu-PVC packaging systems that provide exceptional barrier properties while maintaining compliance with healthcare standards and minimizing operational complexity, particularly important in pharmaceutical and medical facility operations.
Market expansion benefits from healthcare programs that mandate enhanced packaging compliance in pharmaceutical specifications, creating continued demand across Brazil's pharmaceutical and medical sectors, where packaging barrier and system consistency represent critical requirements.
Strategic Market Indicators:
The USA market emphasizes pharmaceutical infrastructure features, including innovative packaging technologies and integration with comprehensive healthcare platforms that manage drug operations, pharmaceutical facilities, and commercial applications through unified packaging systems. The country is projected to show a 4.7% CAGR through 2035, driven by pharmaceutical expansion under healthcare development trends and industry demand for premium, reliable packaging systems. American pharmaceutical companies prioritize innovation with Alu-PVC packages delivering comprehensive healthcare performance through enhanced quality protection and operational advancement.
Technology deployment channels include major pharmaceutical companies, healthcare institutions, and packaging manufacturers that support custom development for pharmaceutical operations.
Performance Metrics:
The UK market demonstrates advanced pharmaceutical infrastructure deployment, growing at 4.2% CAGR, with documented operational excellence in healthcare control and pharmaceutical applications through integration with existing healthcare systems and quality assurance infrastructure. The country leverages engineering expertise in pharmaceutical manufacturing and packaging science to maintain market leadership. Healthcare centers, including London, Manchester, and Cambridge, showcase advanced installations where Alu-PVC packaging systems integrate with comprehensive pharmaceutical platforms and healthcare systems to optimize pharmaceutical development and operational efficiency.
British pharmaceutical facilities prioritize packaging precision and system consistency in product selection, creating demand for premium Alu-PVC packaging systems with advanced features, including enhanced barrier compositions and integration with automated healthcare systems. The market benefits from established pharmaceutical infrastructure and willingness to invest in specialized packaging technologies that provide superior quality and healthcare compliance.
Market Intelligence Brief:
Japan's advanced pharmaceutical market demonstrates meticulous Alu-PVC packaging deployment, growing at 3.7% CAGR, with documented operational excellence in healthcare control and drug applications through integration with existing pharmaceutical systems and quality assurance infrastructure. The country leverages engineering expertise in pharmaceutical manufacturing and packaging technology to maintain market leadership. Pharmaceutical centers, including Tokyo, Osaka, and Nagoya, showcase advanced installations where Alu-PVC packaging systems integrate with comprehensive healthcare platforms and quality systems to optimize pharmaceutical development and operational efficiency.
Japanese pharmaceutical facilities prioritize packaging precision and system consistency in product selection, creating demand for premium Alu-PVC packaging systems with advanced features, including ultra-high quality and integration with automated healthcare protocols. The market benefits from established pharmaceutical infrastructure and willingness to invest in specialized packaging technologies that provide superior performance and healthcare compliance.
Market Intelligence Brief:
The Alu-PVC blister packaging market in Europe is projected to grow from USD 1,562.4 million in 2025 to USD 2,521.8 million by 2035, registering a CAGR of 4.9% over the forecast period. Germany is expected to maintain its leadership position with a 34.7% market share in 2025, declining slightly to 34.3% by 2035, supported by its pharmaceutical excellence and major healthcare centers, including Baden-Württemberg and Bavaria.
France follows with a 26.8% share in 2025, projected to reach 27.1% by 2035, driven by comprehensive pharmaceutical programs and healthcare facility initiatives. The United Kingdom holds a 18.9% share in 2025, expected to maintain 19.2% by 2035 through established healthcare sectors and pharmaceutical adoption. Italy commands a 12.4% share, while Spain accounts for 4.6% in 2025. The Rest of Europe region is anticipated to gain momentum, expanding its collective share from 2.6% to 2.8% by 2035, attributed to increasing pharmaceutical development in Eastern European countries and emerging healthcare programs implementing standardized packaging systems.
The Alu-PVC blister packaging market operates with moderate concentration, featuring approximately 15-22 participants, where leading companies control roughly 58-64% of the global market share through established distribution networks and comprehensive product portfolio capabilities. Competition emphasizes packaging performance, pharmaceutical reliability, and barrier optimization rather than premium feature rivalry.
Market leaders encompass AptarGroup, Tekni-Plex, and West Pharmaceutical Services, which maintain competitive advantages through extensive pharmaceutical infrastructure expertise, regional distribution networks, and comprehensive technical support capabilities that create healthcare industry loyalty and support pharmaceutical requirements. These companies leverage decades of packaging experience and ongoing healthcare technology investments to develop advanced Alu-PVC packaging systems with exceptional quality and pharmaceutical features.
Specialty challengers include regional manufacturers and packaging specialists, which compete through specialized application innovation focus and efficient production solutions that appeal to pharmaceutical buyers seeking reliable performance formats and custom packaging flexibility. These companies differentiate through operational efficiency focus and specialized market focus.
Market dynamics favor participants that combine consistent packaging performance with advanced pharmaceutical support, including automated systems and distribution capabilities. Competitive pressure intensifies as traditional packaging manufacturers expand into Alu-PVC systems. At the same time, specialized pharmaceutical producers challenge established players through innovative manufacturing methods and cost-effective production targeting emerging healthcare segments.
| Item | Value |
|---|---|
| Quantitative Units | USD 5,579.9 million |
| Type | Standard Blister Packs, Thermoformed Blister Packs, Cold-Formed Blister Packs, Others |
| Application | Pharmaceutical Products, Cosmetics Products, Others |
| End-Use Industry | Pharmaceutical Manufacturing, Healthcare Distribution, Medical Devices, Consumer Healthcare, Hospital Pharmacy, Retail Pharmacy |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Countries Covered | China, India, Germany, Brazil, USA, UK, Japan, and 25+ additional countries |
| Key Companies Profiled | AptarGroup, Tekni-Plex, West Pharmaceutical Services, Amcor |
| Additional Attributes | Dollar sales by type and application categories, regional adoption trends across Asia Pacific, North America, and Europe, competitive landscape with packaging manufacturers and pharmaceutical producers, customer preferences for packaging characteristics and pharmaceutical performance, integration with pharmaceutical equipment and healthcare systems, innovations in packaging technology and advanced healthcare systems, and development of specialized packaging solutions with enhanced properties and pharmaceutical-grade features |
The global alu-pvc blister packaging market is estimated to be valued at USD 5.6 billion in 2025.
The market size for the alu-pvc blister packaging market is projected to reach USD 9.0 billion by 2035.
The alu-pvc blister packaging market is expected to grow at a 4.9% CAGR between 2025 and 2035.
The key product types in alu-pvc blister packaging market are standard blister packs, thermoformed blister packs, cold-formed blister packs and others.
In terms of application, pharmaceutical products segment to command 74.3% share in the alu-pvc blister packaging market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Blister Card Market Analysis by Product Type, Technology Type, Material Type, End-use Industry, and Region Forecast Through 2035
Blister Paper Market
Blister Packaging Market Size and Share Forecast Outlook 2025 to 2035
Competitive Overview of Blister Packaging Companies
Deblistering Machines Market Size and Share Forecast Outlook 2025 to 2035
Market Share Breakdown of Leading Deblistering Machine Providers
PVC Blister Packs Market
USA Blister Packaging Market Trends – Demand & Growth 2025-2035
Japan Blister Packaging Market Trends – Demand & Growth 2025-2035
Welded Blisters Market Size and Share Forecast Outlook 2025 to 2035
Pharma Blister Packaging Machines Market Size and Share Forecast Outlook 2025 to 2035
Competitive Overview of Pharma Blister Packaging Machines Industry Share
Leading Providers & Market Share in Pharma Blister Packaging
Carded Blister Packaging Market
Sliding Blister Packaging Market Size and Share Forecast Outlook 2025 to 2035
Alu Alu Blister Packaging Machine Market Insights - Trends & Forecast 2025 to 2035
Understanding Market Share Trends in Alu-Alu Blister Packaging Machines
Germany Blister Packaging Market Size – Demand & Growth 2025-2035
Global Medicine Blister Market Analysis – Growth & Forecast 2025 to 2035
Holographic Blister Foil Market Forecast Outlook 2025 to 2035
Alu-PVC Blister Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
